ExeVir Bio makes two appointments to board of directors
Belgium-based ExeVir Bio BV has appointed Michel Kazatchkine and Stef Heylen to its board of directors. The company is developing nanobody therapies providing broad protection against viral infections, including a lead candidate targeting for coronaviruses.
Belgium